MoneyWorks4Me

The sales slipped to Rs. 54.81 millions, down -57.48% for the June 2025 quarter as against Rs. 128.89 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -53.24 millions as compared to Net Loss of Rs. -51.71 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 further decreased to -20.75% as compared to -21.63% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 54.81 128.89 -57.48 54.81 128.89 -57.48 433.12 504.22 -14.10
Other Income 0.12 0.34 -64.71 0.12 0.34 -64.71 7.09 4.51 57.21
PBIDT -20.75 -21.63 -4.07 -20.75 -21.63 -4.07 -143.21 -82.72 73.13
Interest 16.50 13.18 25.19 16.50 13.18 25.19 59.14 46.89 26.12
PBDT -37.25 -34.81 7.01 -37.25 -34.81 7.01 -202.35 -129.61 56.12
Depreciation 15.99 16.90 -5.38 15.99 16.90 -5.38 66.89 67.66 -1.14
PBT -53.24 -51.71 2.96 -53.24 -51.71 2.96 -269.24 -197.27 36.48
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -53.24 -51.71 2.96 -53.24 -51.71 2.96 -269.39 -197.27 36.56
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) -37.86 -16.78 125.59 -37.86 -16.78 125.59 -33.06 -16.41 101.55
Peers
Company Name CMP
Sun Pharma. Inds. 1860.70
Dr. Reddys Labs. 1204.50
Cipla 1412.25
Lupin 2106.10
Zydus Lifesciences 1179.25
View more..